06/19/2002
By David Loshak
People with vitiligo may have a tumour suppressor gene that protects them from photodamage and non-melanoma skin cancer.
This is suggested by researchers in Greifswald, Germany and Bradford, England, after they failed to find an expected high risk for sun-induced damage and skin cancer in a group (n=136) of patients with vitiligo.
This finding coincided with a recent report on increased functional wild-type p53 gene expression among patients with vitiligo. Noting that ultraviolet radiation was well known to be related to non-melanoma skin cancer in Caucasians, the researchers noted that patients with vitiligo often had no protective pigment in sun-exposed, de-pigmented or white skin.
They also had severe oxidative stress due to accumulation of millimolar epidermal hydrogen peroxide.
These patients might therefore be expected to develop a higher risk for early photodamage and non-melanoma skin cancer. Despite this, however, various reports on small numbers of patients had not documented any increased risk for sun-induced skin cancers in patients with vitiligo.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!